Skin conduction and transport systems

Details Skin conduction and transport systems Skin conduction and transport systems

2006-08-29

2006-08-29

Cohen, Lee S. (Department: 3739)

Surgery

Diagnostic testing

Structure of body-contacting electrode or electrode inserted...

C600S397000, C606S032000, C604S020000, C607S153000

Reexamination Certificate

active

07099713

ABSTRACT:
Surfactants useful for enhancing the electrical conduction of electrodes attached to the surface of a patient. The surfactants are also useful in transport of materials in and out of the body of a patient (animal or human) and in the measurement of disease states. Typical surfactants particularly useful in the invention are broadly represented by protein/fatty acid based compounds. The protein/fatty acid compounds may be lipopolypeptides. In some embodiments the lipopolypeptides may be acyl peptides. Typical acyl peptides are Lamepon S™, MayTein C™ and MayTein CT™.

REFERENCES:
patent: 3027333 (1962-03-01), Friedman
patent: 4229479 (1980-10-01), Brick et al.
patent: 4379454 (1983-04-01), Campbell et al.
patent: 4457748 (1984-07-01), Lattin et al.
patent: 4458686 (1984-07-01), Clark, Jr.
patent: 4473492 (1984-09-01), Schmolka
patent: 4699146 (1987-10-01), Sieverding
patent: 4705682 (1987-11-01), Moeller et al.
patent: 4777954 (1988-10-01), Keusch et al.
patent: 4821733 (1989-04-01), Peck
patent: 4975441 (1990-12-01), Gibson
patent: 5023085 (1991-06-01), Francoeur et al.
patent: 5036861 (1991-08-01), Sembrowich et al.
patent: 5076273 (1991-12-01), Schoendorfer et al.
patent: 5135480 (1992-08-01), Bannon et al.
patent: 5139023 (1992-08-01), Stanley et al.
patent: 5140985 (1992-08-01), Schroeder et al.
patent: 5143071 (1992-09-01), Keusch et al.
patent: 5203327 (1993-04-01), Schoendorfer et al.
patent: 5279543 (1994-01-01), Glikfeld et al.
patent: 5291887 (1994-03-01), Stanley et al.
patent: 5302172 (1994-04-01), Sage et al.
patent: 5334138 (1994-08-01), Sage et al.
patent: 5358714 (1994-10-01), Green
patent: 5441048 (1995-08-01), Schoendorfer
patent: 5443080 (1995-08-01), D'Angelo et al.
patent: 5498420 (1996-03-01), Edgar et al.
patent: 5603693 (1997-02-01), Frenkel et al.
patent: 5636632 (1997-06-01), Bommannan et al.
patent: 5668170 (1997-09-01), Gyory
patent: 5686516 (1997-11-01), Tzur
patent: 5693604 (1997-12-01), Su
patent: 5760096 (1998-06-01), Thornfeldt et al.
patent: 5800685 (1998-09-01), Perrault
patent: 5874095 (1999-02-01), Deckner et al.
patent: 5904917 (1999-05-01), Mattai et al.
patent: 5921925 (1999-07-01), Cartmell et al.
patent: 5952000 (1999-09-01), Venkateshwaran et al.
patent: 5954685 (1999-09-01), Tierney
patent: 5985990 (1999-11-01), Kantner et al.
patent: 5993848 (1999-11-01), Suzuki et al.
patent: 6180416 (2001-01-01), Kurnik et al.
patent: 6232366 (2001-05-01), Wang et al.
patent: 6233471 (2001-05-01), Berner et al.
patent: 6251083 (2001-06-01), Yum et al.
patent: 6297204 (2001-10-01), Picard et al.
patent: 6319913 (2001-11-01), Mak et al.
patent: 2001/0016682 (2001-08-01), Berner et al.
patent: 2001/0036483 (2001-11-01), Luo et al.
patent: 0 295 092 (1988-12-01), None
patent: 0 613 942 (1994-09-01), None
patent: 0 804 155 (1997-11-01), None
patent: WO 96/00110 (1996-01-01), None
patent: WO 00/01351 (2000-01-01), None
patent: WO 00/33812 (2000-06-01), None
Barry, B.W.; Novel Mechanisms and Devices to Enable Successful Transdermal Drug Delivery; European Journal of Pharmaceutical Sciences 14 (2); 2001; pp. 101-114; Elsevier.
Berti, Jeffrey J. et al.; Transcutaneous Drug Delivery: A Practical Review; Mayo Clinic Proceedings.; Jun. 1995; vol. 70(6); pp. 581-586.
Hsu, Chang-Shan et al.; Anionic Gels as Vehicles for Electrically-Moduated Drug Delivery. l. Solvent & Drug Transport Phenomena; Pharrmaceutical Research; vol. 13, No. 12; 1996; pp. 1865-1870.
Kanikkannan, N. et al.; Structure-activity Relationship of Chemical Penetration Enhancers in Transdermal Drug Delivery; Current Medicinal Chemistry; 2000; 7; pp. 593-608.
Panchagnula, Ramesh; Transdermal Iontophoresis Revisited; Next Generation Therapeutics; pp. 468-473.
Peck, Kendall; Flux Enhancement Effects of Ionic Surfactants Upon Passive & Electroosmotic Transdermal Transport; J. of Pharmaceutical Sciences; vol. 87; 9; Sep. 1998;pp. 1161-1169.
Sanderson, John E.; Iontophoretic Delivery of Nonpeptide Drugs: Formulation Optimization for Maximum Skin Permeability; J. of Pharmaceutical Sciences; vol. 78; No. 5; May 1989; pp. 361-364.
Vyas, S.P.; et al.; Percutnaeous Permeation: Principles, Means and Methods to Enhance the Permeation; Indian Drugs; 37(10; Oct. 2000; pp. 454-463.
Wang, Youmin et al.; Effect of Sodium Dodecyl Sulfate on Iontophoresis of Hydrocortisone Across Hairless Mouse Skin; Pharmaceutical Development & Technology; 5(4); pp. 533-542; 2000.
Xu, Ping et al.; Enhanced Skin Permeability for Transdermal Drug Delivery: Physiopathological & Physicochemical Considerations; Critical Reviews in Therapeutic Drug Carrier Systems; 8(3) pp. 211-236; 1991.

Affiliated with

Also associated with

Rating

Skin conduction and transport systems does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Skin conduction and transport systems, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Skin conduction and transport systems will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3686603